-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CmuBf0DzMpljTYp6gKYP49a1Mtrdq/ZUubp0N7hj0EWbT+w3aWalhLAnx8g+KdrR xK5MuCyMaNXM/YQRa/IYMQ== 0000950117-03-001518.txt : 20030416 0000950117-03-001518.hdr.sgml : 20030416 20030416162814 ACCESSION NUMBER: 0000950117-03-001518 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030416 FILED AS OF DATE: 20030416 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACIA CORP /DE/ CENTRAL INDEX KEY: 0000067686 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 430420020 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02516 FILM NUMBER: 03652826 BUSINESS ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 BUSINESS PHONE: 9089018000 MAIL ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CHEMICAL CO DATE OF NAME CHANGE: 19711003 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CO DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: LUND OLOF CENTRAL INDEX KEY: 0001110752 RELATIONSHIP: DIRECTOR FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: LOJTNANTSGATN 21 PO BOX 27801 STREET 2: S-115 93 STOCKHOLM CITY: SWEDEN STATE: V7 ZIP: 00000 BUSINESS PHONE: 3146944492 MAIL ADDRESS: STREET 1: LOJTNANTSGATN 21 PO BOX 27801 STREET 2: S-115 93 STOCKHOLM CITY: SWEDEN STATE: V7 ZIP: 00000 4 1 a34587.txt OLOF LUND Form 4 Page 1 of 2 ---------------------------- - --------------- OMB APPROVAL FORM 4 ---------------------------- - --------------- OMB Number: 3235-0287 ---------------------------- Expires: January 31, 2005 ---------------------------- Estimated average burden hours per response... 0.5 ---------------------------- [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). (Print or Type Responses)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
- ------------------------------------------------------------------------------------------------------------------------ 1. Name and Address of Reporting Person* 2. Issuer Name and Ticker or Trading Symbol Lund, Olof Pharmacia Corporation PHA - ------------------------------------------------------------------------------------------------------------------------ (Last) (First) (Middle) 3. I.R.S. Identification 4. Statement for Number of Reporting Month/Day/Year Person, if an entity (voluntary) 100 Route 206 North April 16, 2003 - ------------------------------------------------------------------------------------------------------------------------ (Street) 5. If Amendment, Date of Original (Month/Day/Year) Peapack, NJ 07977 - ------------------------------------------------------------------------------------------------------------------------ (City) (State) (Zip)
- --------------------------------------------------------------- 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner -------- ------- Officer (give Other (specify -------- title below) ------- below) - --------------------------------------------------------------- 7. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person - ------ Form filed by More than One Reporting Person - ------ - ---------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------------------- Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned - -------------------------------------------------------------------------------------------------------------------------- 1. Title of Security 2. Transaction Date 2A. Deemed 3. Transaction 4. Securities Acquired (A) (Instr. 3) (Month/Day/Year) Execution Code or Disposed of (D) Date, (Instr.8) (Instr. 3, 4 and 5) if any --------------------------------------------------------- (Month/ Code V Amount (A) or Price Day/ (D) Year) - -------------------------------------------------------------------------------------------------------------------------- Common 04/16/2003 J(1) 4,927 D - -------------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------------- - ------------------------------------------------------------------------------------ 5. Amount of 6. Ownership 7. Nature of Securities Form: Direct Indirect Beneficially (D) or Indirect (I) Beneficial Owned Following (Instr. 4) Ownership Reported Transaction(s) (Instr. 4) (Instr. 3 and 4) - ------------------------------------------------------------------------------------ 0 D - ------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------
Form 4 Page 2 of 2 Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) - -------------------------------------------------------------------------------------------------------------------- 1. Title of Derivative 2. Conver- 3. Trans- 3A. Deemed Execution 4. Transac- 5. Number of Security (Instr. 3) sion or action Date, if any tion Code Derivative Exercise Date (Month/Day/Year) (Instr. 8) Securities Price of (Month/ Acquired (A) Derivative Day/ or Disposed of Security Year) (D) (Instr. 3, 4 and 5) ----------------------------------- Code V (A) (D) - -------------------------------------------------------------------------------------------------------------------- Option (right to buy) $43.96 04/16/2003 J(1) 3,768 - -------------------------------------------------------------------------------------------------------------------- Option (right to buy) $50.03 04/16/2003 J(1) 6,966 - -------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------------------- - --------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------- 6. Date Exercisable 7. Title and Amount of 8. Price of 9. Number of and Expiration Date Underlying Securities Derivative Derivative (Month/Day/Year) (Instr. 3 and 4) Security Securities (Instr. 5) Beneficially Owned Following Reported Transaction(s) (Instr. 4) - ------------------------ --------------------------- Date Expi- Title Amount or Exercis- ration Number of able Date Shares - ------------------------------------------------------------------------------------------- (2) 05/03/2009 Common 3,768 0 - ------------------------------------------------------------------------------------------- (2) 06/23/2010 Common 6,966 0 - ------------------------------------------------------------------------------------------- - ------------------------------------------------------------------------------------------- - ------------------------------------------------------------------------------------------- - ------------------------------------------------------------------------------------------- - ------------------------------------------------------------------------------------------- - ------------------------------------------------------------------------------------------- - ------------------------------------ 10. Ownership 11. Nature Form of of Indirect Derivative Beneficial Securities Ownership Beneficially (Instr. 4) Owned at End of Month (Instr. 4) - ----------------------------------- D - ----------------------------------- D - ----------------------------------- - ----------------------------------- - ----------------------------------- - ----------------------------------- - ----------------------------------- - -----------------------------------
Explanation of Responses: (1) Each share of Pharmacia Common Stock (PHA) held by the reporting person was exchanged for 1.4 shares of Pfizer Common Stock (PFE), pursuant to the Pfizer/Pharmacia merger agreement adopted by the Pfizer and Pharmacia shareholders on December 6 & 9, 2002, respectively. (2) Option is currently exercisable. /s/ Don W. Schmitz April 16, 2003 -------------------------------- ----------------- **Signature of Reporting Person Date Don W. Schmitz, attorney-in-fact for Olof Lund Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. *If the form is filed by more than one reporting person, see Instruction 4(b)(v). **Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potentional persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently vaid OMB number. -----END PRIVACY-ENHANCED MESSAGE-----